Evaluation of Plasma Phosphorylated Tau217 for Differentiation between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes among Patients with Corticobasal Syndrome

VandeVrede, L., La Joie, R., Thijssen, E. H., Asken, B. M., Vento, S. A., Tsuei, T., Baker, S. L., Cobigo, Y., Fonseca, C., Heuer, H. W., Kramer, J. H., Ljubenkov, P. A., Rabinovici, G. D., Rojas, J. C., Rosen, H. J., Staffaroni, A. M., Boeve, B. F., Dickerson, B. C., Grossman, M., … Boxer, A. L. (2023). Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome. JAMA Neurology, 80(5), 495. https://doi.org/10.1001/jamaneurol.2023.0488
Authors:
Lawren Vandevrede
Renaud La Joie
Elisabeth H. Thijssen
Breton M. Asken
Stephanie A. Vento
Torie Tsuei
Suzanne L. Baker
Yann Cobigo
Corrina Fonseca
Hilary W. Heuer
Joel H. Kramer
Peter A. Ljubenkov
Gil D. Rabinovici
Julio C. Rojas
Howie J. Rosen
Adam M. Staffaroni
Brad F. Boeve
Brad C. Dickerson
Murray Grossman
Edward D. Huey
David J. Irwin
Irene Litvan
Alexander Y. Pantelyat
Maria Carmela Tartaglia
Jeffrey L. Dage
Adam L. Boxer
Affiliated Authors:
Edward D. Huey
Publication Type:
Article
Unique ID:
10.1001/jamaneurol.2023.0488
PMID:
Journal:
Publication Date:
Data Source:
Scopus

Record Created: